OHI
OMEGA HEALTHCARE INVESTORS INC
NYSE · Real Estate · REIT - Healthcare Facilities · US
$49.10
+3.29%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.3B | 1.2B | 1.1B | 949.7M | 878.2M |
| Cost of Revenue | 358.8M | 664.9M | 14.6M | 15.0M | 15.5M |
| Gross Profit | 621.6M | 533.2M | 1.0B | 934.7M | 862.7M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 54.6M | — | 88.0M | 81.5M | 69.4M |
| General & Admin Expense | 54.6M | — | 88.0M | 81.5M | 69.4M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (18.7M) | (216.3M) | 289.2M | 364.2M | 401.1M |
| Total Operating Expenses | 35.9M | (216.3M) | 377.2M | 445.7M | 470.5M |
| Cost and Expenses | 380.4M | 448.7M | 391.7M | 460.8M | 486.0M |
| Operating Income (EBIT) | 600.0M | 749.4M | 659.7M | 489.0M | 392.3M |
| Non-Operating | |||||
| Interest Income | 90.9M | 175.1M | — | — | — |
| Interest Expense | 194.3M | 220.5M | 221.7M | 235.5M | 233.2M |
| Net Interest Income | (58.8M) | (45.4M) | (221.7M) | (235.5M) | (233.2M) |
| Other Non-Op Income/Expense | 122.1M | (125.2M) | (231.0M) | (233.9M) | 51.1M |
| Non-Operating Income (excl Interest) | (268.1M) | (95.3M) | 17.2M | (2.2M) | (277.1M) |
| EBT (Pre-Tax Income) | 807.5M | 624.2M | 428.7M | 255.1M | 443.4M |
| Income Tax Expense | 9.0M | 14.7M | 10.9M | 6.3M | 4.6M |
| Bottom Line | |||||
| Net Income | 766.8M | 590.1M | 406.3M | 242.2M | 426.9M |
| Earnings from Cont. Ops | 710.2M | 609.5M | 417.8M | 248.8M | 438.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 674.3M | 590.1M | 418.4M | 249.3M | 438.8M |
| Per Share | |||||
| Basic EPS | $2.26 | $2.02 | $1.57 | $1.01 | $1.81 |
| Diluted EPS | $2.21 | $1.94 | $1.55 | $1.00 | $1.80 |
| Revenue Per Share | — | $4.05 | $4.07 | $3.95 | $3.72 |
| Shares | |||||
| Basic Shares Outstanding | — | 296.1M | 258.1M | 240.5M | 236.3M |
| Diluted Shares Outstanding | — | 310.7M | 270.4M | 250.5M | 244.3M |
| Profitability Metrics | |||||
| EBITDA | 1.3B | 1.2B | 947.1M | 810.8M | 1.0B |
| D&A | 330.8M | 325.2M | 304.6M | 319.7M | 332.4M |
| EBIT | 868.0M | 844.8M | 642.5M | 491.2M | 669.4M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026